gene expression Latest News

A novel therapeutic approach called exon skipping involves bypassing a disease-causing mutation in a gene to restore normal gene expression and protein production.

Those that missed last month's event can get a CD with 80 speaker presentations from 4 pipelines: formulation, purification, biotherapeutics, and expression. Individual track CDs and the overall event CD is available at CHI-PepTalk.com.

Small RNA-based nucleic acid drugs represent a promising new class of therapeutic agents for silencing abnormal or overactive disease-causing genes, and researchers have discovered new mechanisms by which RNA drugs can control gene activity.

Sophisticated genetic tools and techniques for achieving targeted gene delivery and high gene expression levels in bone marrow will drive the successful application of gene therapy to treat a broad range of diseases.

Sigma® Life Science and King's College London co-developing miRNA Target Identification Technology

GenUs BioSystems announces a combined miRNA and whole genome gene expression service. Standard combined service for yields as low as 400 nanograms. Special application services are also available for much smaller yields.

GenUs BioSystems announces a 70% reduction in the minimum RNA yield requirement for standard gene expression services to 300 nanograms. Special services are available for yields down to 100 picograms RNA.

A novel technique for carrying out gene-expression profiling is set to challenge the market dominance of the current, widely used methodology, reports Genetic Engineering & Biotechnology News (GEN).

Advanced API now available in Biotracker™ 4.1. The unique API makes it easier for our customers and consulting partners to develop advanced research applications.

Global alliance enables gene expression profiling from challenging clinical samples

Ocimum Biosolutions now offers complete sequencing solution to all reserach , pharma and biotech laboratories

GenScript's continuous improvement of its OptimumGene TM design platform has reached a new critical mass for gene synthesis and expression.